Castle Biosciences
Pre-clinicalCastle Biosciences delivers advanced molecular diagnostics and prognostic tests - including genomic profiling for melanoma, skin cancers, Barrett’s esophagus and more - empowering clinicians and patients with personalized insights to guide better care decisions.
Founded
2008
Focus
Diagnostics
About
Castle Biosciences delivers advanced molecular diagnostics and prognostic tests - including genomic profiling for melanoma, skin cancers, Barrett’s esophagus and more - empowering clinicians and patients with personalized insights to guide better care decisions.
Funding History
7Total raised: $225M
IPO$75MUndisclosedJul 25, 2019
IPO$45MUndisclosedJun 19, 2019
Series B$30MRiverVest Venture PartnersAug 15, 2017
Series C$30MUndisclosedJun 15, 2015
Company Info
TypePrivate
Founded2008
LocationFriendswood, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile